Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 17, 2023

SELL
$107.43 - $135.93 $35,989 - $45,536
-335 Closed
0 $0
Q3 2021

Sep 11, 2023

BUY
$106.4 - $120.78 $35,644 - $40,461
335 New
335 $36,000
Q3 2021

Feb 17, 2023

BUY
$106.4 - $120.78 $35,644 - $40,461
335 New
335 $36,000
Q2 2017

Feb 09, 2023

SELL
N/A
-69 Closed
0 $0
Q1 2017

Aug 29, 2023

BUY
N/A
69 New
69 $0
Q4 2016

Feb 09, 2023

BUY
N/A
69
69 $4,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Artemis Wealth Advisors, LLC Portfolio

Follow Artemis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.